166 related articles for article (PubMed ID: 1649896)
1. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers.
Yao QY; Rowe M; Martin B; Young LS; Rickinson AB
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1579-90. PubMed ID: 1649896
[TBL] [Abstract][Full Text] [Related]
2. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx.
Gratama JW; Oosterveer MA; Weimar W; Sintnicolaas K; Sizoo W; Bolhuis RL; Ernberg I
J Gen Virol; 1994 Jan; 75 ( Pt 1)():85-94. PubMed ID: 8113743
[TBL] [Abstract][Full Text] [Related]
3. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
Buisson M; Morand P; Genoulaz O; Bourgeat MJ; Micoud M; Seigneurin JM
J Gen Virol; 1994 Feb; 75 ( Pt 2)():431-7. PubMed ID: 8113767
[TBL] [Abstract][Full Text] [Related]
4. One-step typing of Epstein-Barr virus by polymerase chain reaction: predominance of type 1 virus in Japan.
Kunimoto M; Tamura S; Tabata T; Yoshie O
J Gen Virol; 1992 Feb; 73 ( Pt 2)():455-61. PubMed ID: 1311368
[TBL] [Abstract][Full Text] [Related]
5. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx.
Alfieri C; Tanner J; Carpentier L; Perpête C; Savoie A; Paradis K; Delage G; Joncas J
Blood; 1996 Jan; 87(2):812-7. PubMed ID: 8555507
[TBL] [Abstract][Full Text] [Related]
7. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
[TBL] [Abstract][Full Text] [Related]
8. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers.
Oosterveer MA; Markusse HM; Lennette ET; Zou JZ; Bolhuis RL; Gratama JW
J Med Virol; 1993 Dec; 41(4):261-9. PubMed ID: 8106859
[TBL] [Abstract][Full Text] [Related]
10. A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.
Sixbey JW; Shirley P; Sloas M; Raab-Traub N; Israele V
J Infect Dis; 1991 May; 163(5):1008-15. PubMed ID: 1850440
[TBL] [Abstract][Full Text] [Related]
11. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
12. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
13. The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.
Falk K; Gratama JW; Rowe M; Zou JZ; Khanim F; Young LS; Oosterveer MA; Ernberg I
J Gen Virol; 1995 Apr; 76 ( Pt 4)():779-90. PubMed ID: 9049323
[TBL] [Abstract][Full Text] [Related]
14. A strategy for precision of genotyping of Epstein-Barr virus by polymerase chain reaction: application for studying Hodgkin's lymphoma.
Lin JC; Lin SC; Mar EC
Leuk Lymphoma; 1994 Nov; 15(5-6):389-97. PubMed ID: 7873996
[TBL] [Abstract][Full Text] [Related]
15. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.
Yao QY; Tierney RJ; Croom-Carter D; Dukers D; Cooper GM; Ellis CJ; Rowe M; Rickinson AB
J Virol; 1996 Aug; 70(8):4884-94. PubMed ID: 8763991
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.
Sample J; Young L; Martin B; Chatman T; Kieff E; Rickinson A; Kieff E
J Virol; 1990 Sep; 64(9):4084-92. PubMed ID: 2166806
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.
Brooks JM; Croom-Carter DS; Leese AM; Tierney RJ; Habeshaw G; Rickinson AB
J Virol; 2000 Feb; 74(4):1801-9. PubMed ID: 10644353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
